BRPI0916480A2 - composto de fórmula geral (i) e uso de pelo menos um composto - Google Patents
composto de fórmula geral (i) e uso de pelo menos um compostoInfo
- Publication number
- BRPI0916480A2 BRPI0916480A2 BRPI0916480A BRPI0916480A BRPI0916480A2 BR PI0916480 A2 BRPI0916480 A2 BR PI0916480A2 BR PI0916480 A BRPI0916480 A BR PI0916480A BR PI0916480 A BRPI0916480 A BR PI0916480A BR PI0916480 A2 BRPI0916480 A2 BR PI0916480A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19346008P | 2008-12-02 | 2008-12-02 | |
| FR0858207A FR2939135B1 (fr) | 2008-12-02 | 2008-12-02 | Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| PCT/EP2009/066268 WO2010063774A1 (en) | 2008-12-02 | 2009-12-02 | Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0916480A2 true BRPI0916480A2 (pt) | 2016-06-14 |
| BRPI0916480B1 BRPI0916480B1 (pt) | 2019-01-15 |
Family
ID=40852143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0916480A BRPI0916480B1 (pt) | 2008-12-02 | 2009-12-02 | composto de fórmula geral (i) e uso de pelo menos um composto |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US8299259B2 (pt) |
| EP (2) | EP2907804A1 (pt) |
| JP (1) | JP5346092B2 (pt) |
| KR (1) | KR101308808B1 (pt) |
| CN (2) | CN102224139B (pt) |
| AR (1) | AR074453A1 (pt) |
| AU (1) | AU2009324081B2 (pt) |
| BR (1) | BRPI0916480B1 (pt) |
| CA (1) | CA2742709C (pt) |
| ES (1) | ES2536072T3 (pt) |
| FR (1) | FR2939135B1 (pt) |
| MX (1) | MX2011005478A (pt) |
| RU (1) | RU2499794C2 (pt) |
| WO (1) | WO2010063774A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2939135B1 (fr) * | 2008-12-02 | 2010-12-03 | Galderma Res & Dev | Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| FR2953834B1 (fr) * | 2009-12-10 | 2012-01-13 | Galderma Res & Dev | Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| FR3000065A1 (fr) | 2012-12-21 | 2014-06-27 | Univ Lille Ii Droit & Sante | Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes |
| US9650337B2 (en) | 2013-02-14 | 2017-05-16 | Galderma Research & Development | Method of synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same and novel compound tert-butyl 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylate |
| US10772807B2 (en) | 2013-12-04 | 2020-09-15 | Galderma Research & Development | Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use of same in dermatology |
| JP6492531B2 (ja) * | 2014-10-27 | 2019-04-03 | セイコーエプソン株式会社 | 表示装置、及び、表示装置の制御方法 |
| EP3302421B1 (fr) * | 2015-05-29 | 2021-07-07 | Galderma Research & Development | Compositions comprenant au moins un principe actif disperse et des microcapsules lipidiques |
| JP6874250B2 (ja) * | 2015-07-23 | 2021-05-19 | ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． | 新規な選択的１１−ベータ−ヒドロキシステロイド脱水素酵素１型 |
| SI3668853T1 (sl) * | 2017-08-16 | 2022-02-28 | Glaxosmithkline Intellectual Propery Development Limited | Nove spojine |
| WO2019140188A1 (en) * | 2018-01-11 | 2019-07-18 | Centaurus Therapeutics | Inhibitors of dihydroceramide desaturase for treating disease |
| CN109020996B (zh) * | 2018-09-03 | 2020-09-11 | 常州工程职业技术学院 | 一种具有光活性的杂多环化合物及其制备方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0651619B2 (ja) | 1988-05-09 | 1994-07-06 | 株式会社クラレ | 美白剤 |
| FR2704428B1 (fr) | 1993-04-29 | 1995-06-09 | Oreal | Utilisation de dérivés de la résorcine substitués en position(s) 4, 4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante. |
| BR9803596A (pt) | 1997-09-23 | 2000-04-25 | Pfizer Prod Inc | Derivados do resorcinol. |
| BR0009211A (pt) * | 1999-03-22 | 2001-12-26 | Pfizer | Derivados de resorcinol |
| HN2000000033A (es) * | 1999-03-22 | 2001-02-02 | Pfizer Prod Inc | Composicion de resorcinol |
| EP1317425B1 (en) * | 2000-09-11 | 2004-11-03 | Pfizer Products Inc. | Resorcinol derivatives |
| AU2001284362A1 (en) * | 2000-09-21 | 2002-04-02 | Pfizer Products Inc. | Resorcinol derivatives |
| US6852310B2 (en) | 2002-08-23 | 2005-02-08 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Skin lightening agents, compositions and methods |
| US6875425B2 (en) | 2002-12-12 | 2005-04-05 | Unilever Home & Personal Care Usa | Skin lightening agents, compositions and methods |
| US7727998B2 (en) * | 2003-02-10 | 2010-06-01 | Banyu Pharmaceutical Co., Ltd. | Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| CA2512886A1 (en) * | 2003-02-28 | 2004-09-10 | Galderma Research & Development, S.N.C. | Ligands that modulate lxr-type receptors |
| US7300646B2 (en) | 2004-02-27 | 2007-11-27 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Skin lightening agents, compositions and methods |
| US20060210498A1 (en) | 2005-03-18 | 2006-09-21 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Novel resorcinol derivatives for skin |
| US20060210497A1 (en) | 2005-03-18 | 2006-09-21 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Novel resorcinol derivatives |
| DE102005061657A1 (de) * | 2005-06-16 | 2006-12-28 | Merck Patent Gmbh | Verwendung von substituierten Piperazin- und Morpholinderivaten |
| FR2937972B1 (fr) * | 2008-11-04 | 2013-03-29 | Galderma Res & Dev | Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| FR2937973B1 (fr) * | 2008-11-04 | 2010-11-05 | Galderma Res & Dev | Modulateurs des recepteurs de la melanocortine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| FR2939135B1 (fr) * | 2008-12-02 | 2010-12-03 | Galderma Res & Dev | Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| FR2939136B1 (fr) * | 2008-12-02 | 2010-12-03 | Galderma Res & Dev | Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
-
2008
- 2008-12-02 FR FR0858207A patent/FR2939135B1/fr not_active Expired - Fee Related
-
2009
- 2009-12-02 RU RU2011127126/04A patent/RU2499794C2/ru active
- 2009-12-02 WO PCT/EP2009/066268 patent/WO2010063774A1/en not_active Ceased
- 2009-12-02 JP JP2011539019A patent/JP5346092B2/ja not_active Expired - Fee Related
- 2009-12-02 KR KR1020117015286A patent/KR101308808B1/ko not_active Expired - Fee Related
- 2009-12-02 EP EP15154368.3A patent/EP2907804A1/en not_active Withdrawn
- 2009-12-02 US US13/131,363 patent/US8299259B2/en not_active Expired - Fee Related
- 2009-12-02 AU AU2009324081A patent/AU2009324081B2/en not_active Ceased
- 2009-12-02 MX MX2011005478A patent/MX2011005478A/es active IP Right Grant
- 2009-12-02 CN CN200980147097.6A patent/CN102224139B/zh not_active Expired - Fee Related
- 2009-12-02 EP EP09763959.5A patent/EP2373620B1/en not_active Not-in-force
- 2009-12-02 AR ARP090104648A patent/AR074453A1/es active IP Right Grant
- 2009-12-02 CN CN201410539219.9A patent/CN104666299A/zh active Pending
- 2009-12-02 ES ES09763959.5T patent/ES2536072T3/es active Active
- 2009-12-02 BR BRPI0916480A patent/BRPI0916480B1/pt not_active IP Right Cessation
- 2009-12-02 CA CA2742709A patent/CA2742709C/en active Active
-
2012
- 2012-09-12 US US13/611,546 patent/US8697726B2/en active Active
-
2014
- 2014-03-07 US US14/200,954 patent/US20140187532A1/en not_active Abandoned
- 2014-08-29 US US14/469,199 patent/US8993596B2/en active Active
-
2015
- 2015-03-17 US US14/659,800 patent/US20150191451A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2011127126A (ru) | 2013-01-10 |
| EP2373620B1 (en) | 2015-03-18 |
| US20150191451A1 (en) | 2015-07-09 |
| FR2939135A1 (fr) | 2010-06-04 |
| KR20110091803A (ko) | 2011-08-12 |
| MX2011005478A (es) | 2011-06-20 |
| CN102224139B (zh) | 2014-11-19 |
| JP5346092B2 (ja) | 2013-11-20 |
| EP2907804A1 (en) | 2015-08-19 |
| US8299259B2 (en) | 2012-10-30 |
| FR2939135B1 (fr) | 2010-12-03 |
| AR074453A1 (es) | 2011-01-19 |
| RU2499794C2 (ru) | 2013-11-27 |
| WO2010063774A1 (en) | 2010-06-10 |
| US8993596B2 (en) | 2015-03-31 |
| ES2536072T3 (es) | 2015-05-20 |
| JP2012510504A (ja) | 2012-05-10 |
| AU2009324081B2 (en) | 2012-10-11 |
| CN104666299A (zh) | 2015-06-03 |
| CA2742709C (en) | 2013-10-08 |
| US20140371197A1 (en) | 2014-12-18 |
| EP2373620A1 (en) | 2011-10-12 |
| CN102224139A (zh) | 2011-10-19 |
| US20130023516A1 (en) | 2013-01-24 |
| AU2009324081A1 (en) | 2010-06-10 |
| US20110311466A1 (en) | 2011-12-22 |
| US20140187532A1 (en) | 2014-07-03 |
| CA2742709A1 (en) | 2010-06-10 |
| BRPI0916480B1 (pt) | 2019-01-15 |
| US8697726B2 (en) | 2014-04-15 |
| KR101308808B1 (ko) | 2013-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0916480A2 (pt) | composto de fórmula geral (i) e uso de pelo menos um composto | |
| BRPI0906186A2 (pt) | composto e uso de um composto | |
| BR112012015366A2 (pt) | compostos de fórmula (i), uso cosmético e uso de um composto | |
| CR20130360A (es) | Compuesto heterocíclico y su uso | |
| BRPI0920263A2 (pt) | composto, uso do composto, composição, e, método | |
| BRPI0818003A2 (pt) | inibidores de csf-1r, composições e métodos de uso | |
| BRPI0911688A2 (pt) | "compostos de pirimidina, composições e métodos de uso" | |
| BRPI0915137A2 (pt) | uso de pelo menos um composto, peptídeo, e, formulação farmacêutica | |
| BRPI0915134A2 (pt) | composto, e, uso de um composto | |
| BRPI0915231A2 (pt) | compostos inibidores de quinase e métodos de uso | |
| BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0717411A2 (pt) | Uso de inibidores de iap | |
| DK1981859T3 (da) | Fremstilling af delmopinol | |
| BRPI0913086A2 (pt) | Composições antimicrobianas e métodos de uso | |
| BRPI0812159A2 (pt) | inibidores de csf-1r, composições e métodos de uso | |
| BRPI0915136A2 (pt) | uso de pelo menos um composto, peptídeo, e, formulação farmacêutica | |
| BRPI0813627A2 (pt) | Peptídio antimicrobiano, composições e métodos de uso | |
| BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
| BRPI0913934A2 (pt) | compostos tendo propriedades antivirais | |
| BRPI0913833A2 (pt) | uso de corantes ácidos | |
| BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
| BRPI0911332A2 (pt) | composições e uso de inibidores de epas1 | |
| BRPI0916504A2 (pt) | composto e uso de pelo menos um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/12/2009, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 14A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2751 DE 26-09-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |